CN114028486A - Propolis stomach invigorating pill - Google Patents
Propolis stomach invigorating pill Download PDFInfo
- Publication number
- CN114028486A CN114028486A CN202110617749.0A CN202110617749A CN114028486A CN 114028486 A CN114028486 A CN 114028486A CN 202110617749 A CN202110617749 A CN 202110617749A CN 114028486 A CN114028486 A CN 114028486A
- Authority
- CN
- China
- Prior art keywords
- gastritis
- stomach
- effects
- propolis
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002784 stomach Anatomy 0.000 title claims abstract description 38
- 241000241413 Propolis Species 0.000 title claims abstract description 20
- 229940069949 propolis Drugs 0.000 title claims abstract description 20
- 239000006187 pill Substances 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 39
- 208000007882 Gastritis Diseases 0.000 claims abstract description 24
- 208000016644 chronic atrophic gastritis Diseases 0.000 claims abstract description 21
- 208000004300 Atrophic Gastritis Diseases 0.000 claims abstract description 20
- 208000036495 Gastritis atrophic Diseases 0.000 claims abstract description 20
- 208000005718 Stomach Neoplasms Diseases 0.000 claims abstract description 7
- 206010017758 gastric cancer Diseases 0.000 claims abstract description 7
- 201000011549 stomach cancer Diseases 0.000 claims abstract description 7
- 229940079593 drug Drugs 0.000 claims description 21
- 240000007311 Commiphora myrrha Species 0.000 claims description 11
- 235000006965 Commiphora myrrha Nutrition 0.000 claims description 11
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 11
- 241000218176 Corydalis Species 0.000 claims description 10
- 239000004863 Frankincense Substances 0.000 claims description 9
- 235000003717 Boswellia sacra Nutrition 0.000 claims description 8
- 240000007551 Boswellia serrata Species 0.000 claims description 8
- 235000012035 Boswellia serrata Nutrition 0.000 claims description 8
- 235000006040 Prunus persica var persica Nutrition 0.000 claims description 8
- 244000144730 Amygdalus persica Species 0.000 claims description 7
- 244000080767 Areca catechu Species 0.000 claims description 6
- 241000237502 Ostreidae Species 0.000 claims description 6
- 235000020636 oyster Nutrition 0.000 claims description 6
- 241000270666 Testudines Species 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 4
- 239000009910 sargent gloryvine Substances 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 235000006226 Areca catechu Nutrition 0.000 claims description 3
- 241000007126 Codonopsis pilosula Species 0.000 claims description 3
- 241000037740 Coptis chinensis Species 0.000 claims description 3
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 3
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 3
- 208000000718 duodenal ulcer Diseases 0.000 claims description 3
- 241000632227 Antenoron Species 0.000 claims description 2
- 244000301850 Cupressus sempervirens Species 0.000 claims description 2
- 241000287828 Gallus gallus Species 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 240000007284 Stenochlaena palustris Species 0.000 claims description 2
- 240000001949 Taraxacum officinale Species 0.000 claims description 2
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 229920002261 Corn starch Polymers 0.000 claims 1
- 240000004980 Rheum officinale Species 0.000 claims 1
- 235000008081 Rheum officinale Nutrition 0.000 claims 1
- 206010009887 colitis Diseases 0.000 claims 1
- 239000008120 corn starch Substances 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 238000011049 filling Methods 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 229940126680 traditional chinese medicines Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 64
- 210000004185 liver Anatomy 0.000 abstract description 31
- 210000000232 gallbladder Anatomy 0.000 abstract description 20
- 210000000952 spleen Anatomy 0.000 abstract description 19
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 13
- 208000026435 phlegm Diseases 0.000 abstract description 13
- 208000024891 symptom Diseases 0.000 abstract description 13
- 201000010099 disease Diseases 0.000 abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 238000011282 treatment Methods 0.000 abstract description 11
- 208000004880 Polyuria Diseases 0.000 abstract description 7
- 230000035619 diuresis Effects 0.000 abstract description 7
- 231100000419 toxicity Toxicity 0.000 abstract description 5
- 230000001988 toxicity Effects 0.000 abstract description 5
- 208000023652 chronic gastritis Diseases 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 4
- 230000001575 pathological effect Effects 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 2
- 210000002429 large intestine Anatomy 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 description 42
- 210000004369 blood Anatomy 0.000 description 32
- 239000008280 blood Substances 0.000 description 32
- 206010061218 Inflammation Diseases 0.000 description 23
- 230000004054 inflammatory process Effects 0.000 description 22
- 229940037467 helicobacter pylori Drugs 0.000 description 16
- 241000590002 Helicobacter pylori Species 0.000 description 15
- 206010028980 Neoplasm Diseases 0.000 description 15
- 208000025865 Ulcer Diseases 0.000 description 14
- 231100000397 ulcer Toxicity 0.000 description 14
- 208000002193 Pain Diseases 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 230000001717 pathogenic effect Effects 0.000 description 12
- 230000017531 blood circulation Effects 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 9
- 201000011510 cancer Diseases 0.000 description 9
- 208000032843 Hemorrhage Diseases 0.000 description 8
- 230000003110 anti-inflammatory effect Effects 0.000 description 8
- 230000000740 bleeding effect Effects 0.000 description 8
- 230000004087 circulation Effects 0.000 description 7
- 230000002147 killing effect Effects 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 208000018556 stomach disease Diseases 0.000 description 7
- 239000000341 volatile oil Substances 0.000 description 7
- 229910001369 Brass Inorganic materials 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 6
- 241000194017 Streptococcus Species 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000010951 brass Substances 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- 244000299790 Rheum rhabarbarum Species 0.000 description 5
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 5
- 230000003213 activating effect Effects 0.000 description 5
- 229930013930 alkaloid Natural products 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 208000006766 bile reflux Diseases 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 231100000167 toxic agent Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 239000011573 trace mineral Substances 0.000 description 5
- 235000013619 trace mineral Nutrition 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 208000012895 Gastric disease Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 150000003797 alkaloid derivatives Chemical class 0.000 description 4
- 210000000941 bile Anatomy 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 244000000010 microbial pathogen Species 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 208000007117 Oral Ulcer Diseases 0.000 description 3
- 208000037386 Typhoid Diseases 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 230000000767 anti-ulcer Effects 0.000 description 3
- 208000002399 aphthous stomatitis Diseases 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- 238000001784 detoxification Methods 0.000 description 3
- 230000003467 diminishing effect Effects 0.000 description 3
- 210000003038 endothelium Anatomy 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000004051 gastric juice Anatomy 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- -1 sterol lactones Chemical class 0.000 description 3
- 150000003505 terpenes Chemical class 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 201000008297 typhoid fever Diseases 0.000 description 3
- 241000712461 unidentified influenza virus Species 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 241001480043 Arthrodermataceae Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 208000018522 Gastrointestinal disease Diseases 0.000 description 2
- 241000700721 Hepatitis B virus Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- 244000272264 Saussurea lappa Species 0.000 description 2
- 235000006784 Saussurea lappa Nutrition 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 241000223238 Trichophyton Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 230000004856 capillary permeability Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 230000037304 dermatophytes Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000000244 kidney pelvis Anatomy 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 201000011591 microinvasive gastric cancer Diseases 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- AEQDJSLRWYMAQI-KRWDZBQOSA-N tetrahydropalmatine Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3C[C@H]2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-KRWDZBQOSA-N 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- HRYLQFBHBWLLLL-UHFFFAOYSA-N (+)-costunolide Natural products C1CC(C)=CCCC(C)=CC2OC(=O)C(=C)C21 HRYLQFBHBWLLLL-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- XZRVRYFILCSYSP-OAHLLOKOSA-N (-)-beta-bisabolene Chemical compound CC(C)=CCCC(=C)[C@H]1CCC(C)=CC1 XZRVRYFILCSYSP-OAHLLOKOSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- KNOUERLLBMJGLF-UHFFFAOYSA-N 1-bisabolone Natural products CC(C)=CCCC(C)C1CCC(C)=CC1=O KNOUERLLBMJGLF-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 235000007173 Abies balsamea Nutrition 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000228197 Aspergillus flavus Species 0.000 description 1
- 241001225321 Aspergillus fumigatus Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical class N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- CUGKULNFZMNVQI-UHFFFAOYSA-N Costunolid I Natural products CC1=CCC=C(/C)CCC2C(C1)OC(=O)C2=C CUGKULNFZMNVQI-UHFFFAOYSA-N 0.000 description 1
- 241000522190 Desmodium Species 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 206010059186 Early satiety Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 101710146739 Enterotoxin Proteins 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- 241001480036 Epidermophyton floccosum Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 241000427940 Fusarium solani Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 244000018716 Impatiens biflora Species 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241000737253 Lygodium japonicum Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- MAYJEFRPIKEYBL-OASIGRBWSA-N Obacunone Chemical compound C=1([C@@H]2OC(=O)[C@H]3O[C@@]43[C@]3(C)C(=O)C[C@H]5C(C)(C)OC(=O)C=C[C@]5(C)[C@H]3CC[C@]42C)C=COC=1 MAYJEFRPIKEYBL-OASIGRBWSA-N 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N Tetrahydropalmatine Natural products C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- 241000893963 Trichophyton concentricum Species 0.000 description 1
- 241001480046 Trichophyton schoenleinii Species 0.000 description 1
- 241001480050 Trichophyton violaceum Species 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFPZQHDPZYIEX-UHFFFAOYSA-N alpha-Santonin Natural products C1CC2(C)C=CC(=O)C=C2C2C1C(C)C(=O)O2 TUFPZQHDPZYIEX-UHFFFAOYSA-N 0.000 description 1
- XJHDMGJURBVLLE-BOCCBSBMSA-N alpha-santonin Chemical compound C([C@]1(C)CC2)=CC(=O)C(C)=C1[C@@H]1[C@@H]2[C@H](C)C(=O)O1 XJHDMGJURBVLLE-BOCCBSBMSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 229940091771 aspergillus fumigatus Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- FDABVSXGAMFQQH-XZWHSSHBSA-N berbamunine Chemical compound CN1CCC2=CC(OC)=C(O)C=C2[C@H]1CC1=CC=C(O)C(OC2=CC=C(C=C2)C[C@@H]2N(C)CCC=3C=C(C(=CC=32)O)OC)=C1 FDABVSXGAMFQQH-XZWHSSHBSA-N 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 210000003459 common hepatic duct Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052878 cordierite Inorganic materials 0.000 description 1
- HRYLQFBHBWLLLL-AHNJNIBGSA-N costunolide Chemical compound C1CC(/C)=C/CC\C(C)=C\[C@H]2OC(=O)C(=C)[C@@H]21 HRYLQFBHBWLLLL-AHNJNIBGSA-N 0.000 description 1
- MMTZAJNKISZWFG-UHFFFAOYSA-N costunolide Natural products CC1CCC2C(CC(=C/C=C1)C)OC(=O)C2=C MMTZAJNKISZWFG-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- JSKIRARMQDRGJZ-UHFFFAOYSA-N dimagnesium dioxido-bis[(1-oxido-3-oxo-2,4,6,8,9-pentaoxa-1,3-disila-5,7-dialuminabicyclo[3.3.1]nonan-7-yl)oxy]silane Chemical compound [Mg++].[Mg++].[O-][Si]([O-])(O[Al]1O[Al]2O[Si](=O)O[Si]([O-])(O1)O2)O[Al]1O[Al]2O[Si](=O)O[Si]([O-])(O1)O2 JSKIRARMQDRGJZ-UHFFFAOYSA-N 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 125000002534 ethynyl group Chemical class [H]C#C* 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 208000020694 gallbladder disease Diseases 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 208000030304 gastrointestinal bleeding Diseases 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000001309 inhibitory effect on influenza Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- VSLDMVSILHVDSR-UHFFFAOYSA-N obacunone Natural products CC1(C)OC(=O)C=CC2(C)C1CC(=O)C3(C)C2CCC4(C)C(OC(=O)C5OC345)c6occc6 VSLDMVSILHVDSR-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229940074353 santonin Drugs 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000005671 trienes Chemical class 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Animal Husbandry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The propolis stomach invigorating pill is mainly used for treating long-term chronic gastritis, atrophic gastritis, gastric cancer and the like, has a good treatment effect, and comprehensively conditions liver, gallbladder, spleen, stomach and large intestine according to the pathological characteristics of patients to treat both principal and secondary aspects of diseases. The principal symptoms of this disease are phlegm, dampness, stasis and toxicity, while the principal symptoms of this disease are liver, gallbladder and spleen, which are not coordinated and mutually affected, and the gastritis is obtained. Therefore, the traditional Chinese medicine composition treats the primary symptoms of the gastritis, removes stasis, reduces phlegm and promotes diuresis, treats the primary symptoms of the gastritis, treats both principal and secondary aspects of the gastritis, can quickly cure the gastritis with superficial gastritis in the early stage, and can gradually recover health if the atrophic gastritis and gastric cancer are serious in illness state and are taken uninterruptedly.
Description
The propolis stomach invigorating pill is prepared by continuously searching, researching and perfecting through years of clinical experiments. What are the drugs that make up the formulation? 50 g of longhairy antenoron herb, 40 g of climbing fern spore, 30 g of chicken's gizzard-membrane, 70 g of turtle shell, 50 g of oyster, 50 g of concha arcae, 50 g of frankincense, 50 g of myrrh, 40 g of rhizoma corydalis, 30 g of peach kernel, 40 g of sargentgloryvine stem, 40 g of costustoot, 40 g of areca nut, 50 g of fried rhizoma atractylodis, 40 g of codonopsis pilosula, 30 g of pure propolis, 40 g of dandelion, 50 g of coptis chinensis, 50 g of scutellaria baicalensis, 50 g of golden cypress, 40 g of radix rehmanniae, 30 g of rhubarb, 30 g of nidus vespae and the like.
The formula has the functions of soothing liver, benefiting gallbladder, tonifying qi, harmonizing stomach, strengthening spleen, eliminating dampness, softening and resolving hard mass, removing blood stasis, promoting tissue regeneration, detoxifying, dredging intestine and the like. Effective treatments are possible according to these effects: duodenal ulcer, superficial gastritis, atrophic gastritis, early gastric cancer, etc. What are the most common primary symptoms of these diseases? Often with dyspepsia, epigastric pain, abdominal distension, postprandial fullness, and early satiety, and eating may be aggravated or alleviated. Also has symptoms of anorexia, belch, acid regurgitation, nausea, etc. Some patients may have mental symptoms such as emaciation, hypodynamia, amnesia, depression, etc. Atrophic gastritis, the mucosal surface is somewhat rough and uneven, either granular or nodular. In addition, the fragility of the mucous membrane is easy to increase, and particularly, some symptoms of digestive tract bleeding are easy to occur, and some symptoms of erosion are possibly accompanied. When these symptoms are found, the treatment is carried out actively to prevent the occurrence of gastric cancer.
The pathological mechanism of these diseases is the incoordination between the liver, gallbladder, spleen and stomach, which can affect the stomach to some extent and lead to qi stagnation. People who love qi often suffer from stomachache caused by liver depression, which is called liver qi attacking stomach. Other people often feel anxious and consume liver blood, which causes liver depression and spleen deficiency, and liver and spleen stomach disharmony, which can lead to qi depression and stomachache. Some liver diseases and gallbladder diseases can cause liver depression and qi stagnation, and bile reflux easily occurs to cause gastropathy. On the one hand, the individual eating habits are that the stomach and the spleen are directly injured by overeating and stomach diseases are caused, and in the situations, pathogenic microorganism bacteria are easily infected due to low immunity of the human body. After the infection of the microorganism bacteria, the treatment is not timely or improper, so that the time is prolonged, and chronic gastritis is formed if the chronic gastritis repeatedly attacks. In the early stage of the stomach disease, superficial gastritis is caused by the impairment of qi system, and ulcer or atrophic gastritis is caused by the impairment of blood system with time. When atrophic gastritis occurs, the surface in the stomach is unsmooth, rough and uneven, granular or nodular, or is hardened, crisp and easy to bleed, at this time, the digestion and gastric juice secretion ability of the stomach is reduced, some nutrient substances become turbid phlegm, and the turbid phlegm stays in the stomach, and becomes turbid toxin in the stomach due to bacteria, and with the development of age, the vital qi is deficient and the pathogenic factors are exuberant, so that cells at local focus parts are denatured, and at this time, the gastric cancer is often caused.
The preparation method of the propolis stomach building pill is not complicated, the medicines are prepared according to the proportion of the formula, then the medicines are pulverized into fine powder of 200 meshes by a pulverizer, then the prepared starch adhesive is added to be fully stirred uniformly, and the uniformly mixed fine powder is prepared into water pills by a full-automatic pill making machine. The prepared water-bindered pills are preferably put into a dryer to be dried. When the medicine is used for treating patients, the medicine is taken two to three times a day according to the severity of the illness of the patients, and 8 grams of the medicine is continuously taken for two to three months each time. Depending on the patient's condition, it may be administered for several months to allow adequate control of the disease and gradual recovery of health.
How much the therapeutic effect of the propolis stomach-invigorating pill? According to the feedback condition and summary of a plurality of patients after taking the medicine, the formula has very obvious efficacy, and the total effective rate reaches one hundred percent. The patient can feel after taking the medicine, the abdomen of the patient feels the first feeling of promoting the circulation of qi, the patient can hear the medicine almost by himself, the gurgling in the abdomen makes a sound, and then the patient finds that the patient is smooth in urine and urine. The symptoms of abdominal fullness and distending pain gradually decrease later. The appetite, physical strength, dry mouth, bitter mouth, poor sleep and facial complexion of the patient can be improved simultaneously. After the common patients take the medicine for one to two months, even atrophic gastritis turns negative, and the curative effect is very good. The formula contains the medicines for promoting blood circulation and removing blood stasis, so that pregnant women should be contraindicated. Other drugs such as superficial gastritis, gastric and duodenal ulcer, atrophic gastritis, early stage gastric cancer, etc. can be administered.
What is the principle of composition of the formulation? According to the most common and key pathological features of chronic gastritis and atrophic gastritis, there are only two points, one is the problem of bile reflux and the other is the problem of microbial bacterial infection. Because most of the gastritis patients have bile reflux phenomena of different degrees at present. Bile reflux is related to the pathological changes of the gallbladder itself. In traditional Chinese medicine, the liver and the gallbladder are in the same disease, the liver and the gallbladder are often mutually influenced, the liver influences the gallbladder, and the gallbladder also influences the liver. According to the theory of traditional Chinese medicine, liver and gallbladder are wood, and wood diseases injure spleen soil. Therefore, it is also necessary to treat both gallbladder and liver while treating gastropathy, so that liver, gallbladder and stomach are harmonized with each other in qi movement, rather than in restriction. In addition, the infection of pathogenic microorganism in the stomach is the main cause of gastropathy, especially helicobacter pylori, so effective medicines are required to kill. Secondly, the transportation and transformation functions of the spleen are caused, the stomach diseases are long-term and involve the spleen, the spleen deficiency causes no transportation and transformation capacity, food essence becomes turbid phlegm with bacteria, turbid phlegm forms turbid toxin, the secretion of gastric juice is reduced, the digestion capacity of the stomach is reduced, the nutrient absorption is poor, and qi and blood generated by the spleen are reduced, so that anemia is caused. As the disease progresses, the stomach evolves from superficial gastritis, gradually to atrophic gastritis, or to cancer. Phlegm, damp-stasis and toxicity in the stomach are the secondary factors, and the liver, gallbladder and spleen are the primary factors. Therefore, the actions of removing toxicity, resolving phlegm and removing dampness are the primary actions, and the actions of benefiting gallbladder, soothing liver and strengthening spleen are the primary actions. The therapeutic method adopts the standard concurrent role, and the treatment is mainly to relieve constipation and remove toxicity. The enterotoxin can be reduced due to smooth defecation, so that the detoxification burden of the liver can be relieved, and the liver prefers to achieve normal catharsis, so that the better treatment effect can be obtained when the stomach illness is treated.
The herba Lysimachiae Christinae has effects of promoting diuresis, eliminating jaundice, inducing diuresis for treating stranguria, removing toxic substance and relieving swelling. It has the functions of eliminating calculus, diminishing inflammation, benefiting gallbladder and promoting urination. It contains phenols, brass, glycosides, tannins, volatile oil, amino acids, choline, sterol lactones, p-hydroxybenzoic acid, etc. The herba Lysimachiae Christinae contains polysaccharide components, has good inhibitory effect on Staphylococcus aureus, hemolytic streptococcus, Bacillus subtilis and Escherichia coli, has certain curative effect on dilating blood vessel and preventing thrombosis, and can also enhance immunity of organism. Spora Lygodii has effects of clearing away heat and toxic materials, promoting diuresis, treating stranguria, and eliminating calculus. It mainly contains fatty oil, another water-soluble component, the sea-gold sand element, have very good anti-inflammatory effects, mainly used for treating intrahepatic duct, gallbladder, intrabiliary duct, renal pelvis and bladder, intraureteral silt, calculus, inflammation, etc. have very good effects of removing calculus, diminishing inflammation and promoting bile flow, diuresis, etc. clinically, and have very good curative effect on gastritis. The endothelium corneum Gigeriae Galli has effects of strengthening stomach, resolving food stagnation, and removing calculus and treating stranguria. It has good effects of cleaning and dissolving calculus for garbage, silt, calculus, inflammation, gastritis, etc. in gallbladder, biliary duct, hepatic duct, renal pelvis, bladder and ureter. Meanwhile, the endothelium corneum gigeriae galli contains rich nutrient substances, contains gastric hormone, keratin, trace protease, amylase, various vitamins, bile triene, yellow derivatives of biliverdin, lysine and other 18 amino acids. And trace elements such as aluminum, calcium, chromium, cobalt, copper, iron, manganese, molybdenum, magnesium, zinc and the like. It can be used for treating anemia and ulcer surface healing of atrophic gastritis, and supplementing nutrient substances. The three medicines of the desmodium, the lygodium japonicum and the endothelium corneum gigeriae galli are simultaneously applied, and have the functions of dissolving stone, detoxifying, diminishing inflammation and benefiting gallbladder in the process of treating the gastritis, so that the condition of bile reflux can be effectively relieved, and the three medicines can play a very critical role in treating the gastritis.
Carapax Trionycis preparata has effects of nourishing yin, invigorating kidney, removing toxic substance, nourishing blood, softening and resolving hard mass. The medical research shows that the medicine can raise the immunity of human body, promote the formation of body immunoglobulin and prolong the existence time of body antibody. It can also protect animal liver injury, relieve anemia caused by liver and stomach injury, promote synthesis of intrahepatic protein, and increase content of plasma protein. It has effects in inhibiting mouse transplantation tumor and hepatocellular carcinoma. The roasted turtle shell has the effects of promoting blood circulation, softening hard masses, removing stagnation, resisting cancer and the like, and has good anti-inflammatory and tissue damage repairing effects on the treatment of atrophic gastritis. Concha Ostreae has effects in suppressing hyperactive liver, subsiding yang, softening and resolving hard mass, eliminating phlegm, and resisting gastric acid. Has effects of nourishing kidney yin and promoting blood production due to rich nutrition. The Concha Ostreae also contains taurine, and has effects of promoting bile secretion, discharging neutral fat accumulated in liver, and improving liver detoxification effect. Because the oyster has the effects of nourishing yin, promoting the production of body fluid and nourishing blood, the oyster can promote the generation of gastric juice, so that the stomach yin is not deficient, the digestion capability is enhanced, and the rehabilitation of gastritis patients is facilitated. Concha arcae is salty in taste, has effects of softening and resolving hard mass, eliminating phlegm, promoting blood circulation, removing blood stasis, treating hyperacidity, and resisting cancer. Modern medicine is often used to treat hepatosplenomegaly and tumors of the digestive tract. The three medicines of turtle shell, oyster and concha arcae are applied simultaneously, so that the effects of softening hardness to dissipate stagnation, removing blood stasis and eliminating phlegm, treating soreness and pain, resisting inflammation and resisting cancer are enhanced. Has certain therapeutic effect on liver, gallbladder and stomach, especially on atrophic gastritis with ulcer nodular and strong surface, and has antiinflammatory, repairing and granulation promoting effects.
The Olibanum has effects of promoting blood circulation, activating qi-flowing, removing blood stasis, resisting inflammation, relieving swelling, promoting granulation, and relieving pain. It contains balsam acid, frankincense aliphatic hydrocarbon, olibanic acid, frankincense acid and the like. In addition, the volatile oil is mainly pinene. Has effects in relieving pain, relieving inflammation, increasing leukocyte, accelerating exudation and excretion of inflammation, and promoting wound healing, and the pinene contained therein has effect in eliminating phlegm. The myrrh has the functions of promoting blood circulation and promoting qi circulation, relieving swelling and pain, resisting inflammation and promoting granulation, and removing blood stasis and stopping bleeding. It contains alpha-bisaboloic acid, B-bisaboloic acid, bisabolol, limonene, bisabolone, etc. It has good antiinflammatory effect, and the water immersion agent has different degrees of inhibiting effect on multiple pathogenic dermatophytes such as trichophyton donovani, trichophyton concentricum, trichophyton schoenleinii and the like in test tube, and the antibacterial effect may be related to the contained eugenol. The myrrh has the functions of activating blood and promoting qi circulation, detumescence and promoting granulation, anti-inflammation and sterilization and relieving pain, can activate blood and has good hemostatic effect, so the myrrh has certain hemostatic effect on the hemorrhagic symptoms of atrophic gastritis. Rhizoma corydalis has effects of relieving pain, resisting ulcer, and improving microcirculation. The alcohol extract and water extract of rhizoma corydalis can inhibit the growth of helicobacter pylori, and the rhizoma corydalis total alkaloid has therapeutic effect on histamine ulcer and acetic acid ulcer. The L-tetrahydropalmatine in rhizoma corydalis can reduce erythrocyte aggregation and improve erythrocyte deformability, so that internal friction of blood is reduced, blood viscosity is reduced, erythrocyte can pass through capillary smoothly, and normal microcirculation is maintained. Peach kernel has the functions of promoting blood circulation to disperse blood clots and relaxing bowels. The peach kernel can be used for conditioning and treating clinical symptoms such as abdominal mass, traumatic injury, intestinal dryness and constipation, stasis in human body and the like. In addition, it also contains protein component, and has obvious inhibition effect on the inflammation reaction, so that it has anti-inflammatory effect. Caulis Sargentodoxae has effects of promoting blood circulation for removing blood stasis, nourishing blood, dredging collaterals, dispelling pathogenic wind, removing dampness, clearing heat and detoxicating etc. Is good at treating gastrointestinal diseases and has good effect. It contains emodin, rhubarb methyl ether, B-sitosterol, daucosterol, stearic acid, salidroside, etc. Has modern pharmacological research and obvious inhibiting effect on staphylococcus aureus, streptococcus B, colibacillus, catacoccus, staphylococcus albus, pseudomonas aeruginosa, streptococcus A and escherichia coli. The five medicines of frankincense, myrrh, rhizoma corydalis, peach kernel and sargentgloryvine stem are combined for application, the five medicines of the frankincense, the myrrh, the rhizoma corydalis, the peach kernel and the sargentgloryvine stem have the effects of activating blood circulation, removing blood stasis, promoting the circulation of qi, dredging collaterals, relieving pain, stopping bleeding, detoxifying and resisting inflammation, and the five medicines have the effects of activating blood circulation and guiding medicaments to better permeate into the deep layer of an atrophic focus for treating the stasis seeds caused by atrophic gastritis and injuring the blood system by pathogenic factors.
Radix aucklandiae is warm in nature and has the effects of soothing liver, regulating qi, building stomach and promoting digestion. It has the functions of regulating upper and lower qi, and has excellent curative effect on superficial gastritis, atrophic gastritis, enteritis and cancer. The costus root contains a large amount of volatile oil components including taxol and costunolide, and the substances have good antibacterial effect, can inhibit the growth of streptococcus, staphylococcus aureus and staphylococcus albus, and also have good inhibitory effect on helicobacter pylori. Therefore, the costus root has the functions of antibiosis and antiphlogosis. Therefore, it is very suitable for treating gastropathy. Arecae semen has effects of killing parasite, removing food stagnation, promoting qi circulation, promoting diuresis, and resisting inflammation. Contains various nutrients required by human body, such as fat, areca oil, alkaloid, catechu, choline, etc. Has the effects of inhibiting dermatophytes, influenza virus and helicobacter pylori, and is very suitable for treating superficial gastritis and atrophic gastritis. Rhizoma Atractylodis is warm in nature, and has effects of eliminating dampness, invigorating spleen, warming spleen and stomach, resisting ulcer, dispelling pathogenic wind, and removing dampness. Has good antibacterial, anti-inflammatory and rheumatism treating effects. The volatile oil contained in rhizoma Atractylodis has inhibitory effect on multiple bacteria, such as Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, helicobacter pylori and various fungi. The radix codonopsitis has the effects of strengthening spleen, supplementing qi, harmonizing stomach, moistening lung, nourishing blood, promoting the production of body fluid and the like. It contains alkaloids, acetylenes, terpenes, brass, wood, steroids, and saccharides. Has modern pharmacological research, and has effects of protecting nerve, resisting tumor, resisting oxidation, resisting inflammation, resisting emergency, protecting liver, promoting gastric mucosa generation, resisting tumor, regulating blood sugar and blood lipid, and promoting macrophage phagocytosis. Propolis is warm in nature, has good anti-ulcer effect, can treat oral ulcer, contains more than 30 brass compounds and nearly more than 40 trace elements, and contains 38 trace elements required by human body, and propolis is contained in the propolis. The propolis has the greatest advantages of resisting ulcer and quickly repairing and healing the ulcer. Oral ulcer or toothache and inflammation of teeth, fresh propolis is contained in oral cavity like sugar block, and inflammation of oral ulcer and tooth root can be cured quickly. The pathogenic bacteria of gastrointestinal diseases mainly comprise helicobacter pylori, staphylococcus, streptococcus, proteus, escherichia coli and the like. Propolis is a natural broad-spectrum antibiotic, and has remarkable effect on the pathogenic bacteria. After patients with enteritis, gastritis and gastric ulcer eat the propolis, the propolis can quickly diminish inflammation and relieve pain, and ulcer can heal, so that helicobacter pylori is infected to turn negative. The four medicines of costustoot, fried areca, fried rhizoma atractylodis, codonopsis pilosula and propolis are simultaneously applied, the medicine properties are mild, and the effects of regulating qi, building stomach, eliminating dampness, building spleen, tonifying qi, promoting the production of body fluid, resisting bacteria, promoting granulation, promoting the generation of gastric mucosa, repairing ulcer healing and the like are achieved. Meanwhile, the cool medicine in the formula can play a certain role in regulating cold and heat balance. The six medicines of frankincense, myrrh, rhizoma corydalis, peach kernel, costustoot and areca are applied simultaneously, so that the effects of promoting blood circulation, removing blood stasis, promoting qi circulation and relieving pain are better. It is beneficial to remove phlegm, dampness, turbidity and toxicity in the stomach and to improve the disease. The eight medicines of turtle shell, oyster, concha arcae, frankincense, myrrh, rhizoma corydalis, peach kernel and propolis are combined together for application, the eight medicines have the effects of softening hardness, resolving hard mass, promoting qi circulation, activating blood circulation, resisting ulcer and resisting cancer, can accelerate blood and oxygen supply for tissue cells of an ulcer surface, promote atrophic gastritis or gastric cancer, and can be repaired and healed as fast as possible.
The herba Taraxaci has effects of clearing away heat and toxic materials, relieving swelling, and promoting urination. It contains high nutritive value including taraxacin, choline, organic acid and inulin, carbohydrate, protein, trace elements, etc. Has antimicrobial, antitumor, antiulcer, cholagogic, hepatoprotective, stomach building, and laxative effects. It has antibacterial effect on Staphylococcus aureus, hemolytic streptococcus, Diplococcus pneumoniae, meningococcus, diphtheria, Pseudomonas aeruginosa, Proteus, Shigella dysenteriae, Salmonella typhi, Catalpoccus bacteria, and helicobacter pylori. Rhizoma Coptidis has effects of clearing away heat and toxic materials, promoting diuresis, purging pathogenic fire, and relieving pain. Modern medical research finds that the medicine contains alkaloid, volatile oil, brass, santonin 3, terpenoids, steroids, polysaccharide and the like. It contains active component for resisting hepatitis B, and has strong killing effect on helicobacter pylori. The coptis chinensis has different degrees of inhibition effects on dysentery bacillus, typhoid bacillus, flocculus epidermophyton, cordierite astringent trichophyton and other fungi, and simultaneously has inhibition effects on influenza virus and hepatitis B virus. The Scutellariae radix has antibacterial, antiinflammatory, heat and dampness removing, pathogenic fire purging, and toxic materials clearing away effects. The Scutellariae radix has different degrees of inhibition effects on dysentery bacillus, typhoid bacillus, Epidermophyton floccosum and Trichophyton violaceum. And has inhibitory effect on influenza virus and hepatitis B virus. Modern medical research finds that the scutellaria baicalensis has good inhibiting and killing effects on helicobacter pylori. Cortex Phellodendri has effects in clearing away heat, eliminating dampness, removing toxic materials, treating sore, resisting ulcer, and resisting cancer. It contains berberine, magnoline, sterol, mucus, brass, alkaloid, volatile oil, stigmasterol, and obacunone. Has effects in resisting pathogenic microorganism and pathogenic protozoa. Has antipyretic and antiinflammatory effects. Also has expectorant and antiulcer effects, especially has strong inhibitory effect on helicobacter pylori. Radix rehmanniae has effects in nourishing yin, invigorating kidney, removing toxic substance, relieving inflammation, tonifying heart, promoting urination, loosening bowel to relieve constipation, promoting salivation, replenishing blood, cooling blood, stopping bleeding, protecting liver, and nourishing stomach. Has effects in resisting tumor, resisting aging, enhancing immunity, resisting blood coagulation, resisting pathogenic microorganism and pathogenic protozoa, and killing helicobacter pylori. Radix et rhizoma Rhei has effects of cooling blood, removing toxic substances, clearing pathogenic accumulation, removing blood stasis, and dredging channels. The radix et rhizoma Rhei contains chrysophanol and anthraquinone compounds, and has effects of reducing capillary permeability, improving fragility, stopping bleeding, resisting bacteria, reducing capillary permeability, increasing platelet, resisting tumor, promoting bile flow, and resisting inflammation. Modern medical research finds that rhubarb has a strong inhibiting effect on helicobacter pylori. The rhubarb and the myrrh have the function of hemostasis, the rhubarb cools blood and stops bleeding, and the myrrh removes blood stasis and stops bleeding, and the two medicines have the functions of preventing and treating gastrointestinal bleeding and preventing bleeding of atrophic gastritis. The nidus Vespae is cool in property, enters liver and stomach channels, and has effects of dispelling pathogenic wind, removing toxic substance, killing parasite, resisting inflammation, and resisting cancer. It contains phenolic acids, diphenylalkanes, terpenoids, nitrogen, brass, lipids, volatile oil, trace elements, calcium, magnesium and iron, and abundant proteins, and is beneficial to human health, and can promote regeneration of human cells and enhance functions of human organs. It also has strong effects of dispelling pathogenic wind, removing dampness, removing toxic substance, resisting inflammation, relieving pain, and resisting cancer, and can be used for treating rheumatism and some bacterial and viral infectious diseases. It has inhibiting and killing effects on Staphylococcus aureus, Pseudomonas aeruginosa, typhoid bacillus, Proteus vulgaris, Aspergillus fumigatus, Aspergillus flavus, Fusarium solani, Leuconostoc, helicobacter pylori, etc. in different degrees. The nine medicines are simultaneously applied, so that the effects of relaxing bowel, detoxifying and resisting inflammation are stronger and better, and the effects of clearing and killing bacteria in the stomach and intestinal tracts, especially helicobacter pylori and the like can be effectively achieved.
In conclusion, the propolis stomach invigorating pill takes the treatment principles of soothing liver and benefiting gallbladder, strengthening spleen and stomach, removing blood stasis and promoting tissue regeneration, and clearing intestine and detoxifying, comprehensively detoxifies and cleans the gastrointestinal tract of a human body, and adopts a treatment method of comprehensively conditioning and emphasizing on detoxification and anti-helicobacter pylori so as to achieve the effect of treating diseases. All the medicines in the formula are reasonably matched, conflict does not occur, the medicines supplement each other and act synergistically, the medicine is safe to take, adverse reactions do not exist, the treatment effect is obvious, even if a patient suffers from atrophic gastritis or early gastric cancer, the medicine can achieve a good treatment effect, and the patient gradually improves and recovers health.
Claims (2)
1. The invention relates to a Chinese medicinal formula, in particular to a propolis stomach invigorating pill which is used for treating: superficial gastritis, duodenal ulcer, atrophic gastritis, gastric cancer, and colitis. The combination is as follows: 50 g of longhairy antenoron herb, 40 g of climbing fern spore, 30 g of chicken's gizzard-membrane, 70 g of turtle shell, 50 g of oyster, 50 g of concha arcae, 50 g of frankincense, 50 g of myrrh, 40 g of rhizoma corydalis, 30 g of peach kernel, 40 g of sargentgloryvine stem, 40 g of costustoot, 40 g of areca-nut, 50 g of rhizoma atractylodis, 40 g of codonopsis pilosula, 30 g of propolis, 40 g of dandelion, 50 g of coptis chinensis, 50 g of scutellaria baicalensis, 50 g of golden cypress, 40 g of radix rehmanniae, 30 g of rheum officinale, 30 g of nidus vespae and the like.
2. The preparation method comprises five steps
Firstly, mixing the medicines together according to a formula
Secondly, the mixed traditional Chinese medicines are pulverized into fine powder of 200 meshes by a pulverizer
Thirdly, adding a proper amount of starch paste prepared by corn starch as an adhesive, and fully and uniformly stirring
Fourthly, putting the fine powder which is evenly stirred into a full-automatic pill making machine to prepare water pills
And fifthly, filling the prepared water-bindered pills into a dryer and drying.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110617749.0A CN114028486A (en) | 2021-06-02 | 2021-06-02 | Propolis stomach invigorating pill |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110617749.0A CN114028486A (en) | 2021-06-02 | 2021-06-02 | Propolis stomach invigorating pill |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114028486A true CN114028486A (en) | 2022-02-11 |
Family
ID=80134212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110617749.0A Pending CN114028486A (en) | 2021-06-02 | 2021-06-02 | Propolis stomach invigorating pill |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114028486A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100364594C (en) * | 2006-02-28 | 2008-01-30 | 孟宪安 | Medicine for treating chronic superficial gastritis and peptic ulcer diseases |
CN102145143A (en) * | 2011-03-30 | 2011-08-10 | 李明盛 | Pharmaceutical composition for treatment of gastritis and preparation method of pharmaceutical composition |
CN102423456A (en) * | 2011-11-03 | 2012-04-25 | 徐艳 | Traditional Chinese medicine preparation for treating chronic atrophic gastritis |
CN105902753A (en) * | 2016-07-01 | 2016-08-31 | 师朝进 | Traditional Chinese medicine composition for treating chronic gastritis |
-
2021
- 2021-06-02 CN CN202110617749.0A patent/CN114028486A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100364594C (en) * | 2006-02-28 | 2008-01-30 | 孟宪安 | Medicine for treating chronic superficial gastritis and peptic ulcer diseases |
CN102145143A (en) * | 2011-03-30 | 2011-08-10 | 李明盛 | Pharmaceutical composition for treatment of gastritis and preparation method of pharmaceutical composition |
CN102423456A (en) * | 2011-11-03 | 2012-04-25 | 徐艳 | Traditional Chinese medicine preparation for treating chronic atrophic gastritis |
CN105902753A (en) * | 2016-07-01 | 2016-08-31 | 师朝进 | Traditional Chinese medicine composition for treating chronic gastritis |
Non-Patent Citations (3)
Title |
---|
何永恒: "复方岑柏颗粒剂治疗慢性结肠炎50例", 辽宁中医杂志, vol. 22, no. 12, pages 540 * |
江成林: "辨证治疗慢性结肠炎160例临床观察", 中国现代医生, vol. 46, no. 15, pages 182 - 183 * |
石景洋,等: "治疗老年痴呆病中药应用频次及临床分析", 中国实验方剂学杂志, vol. 19, no. 08, pages 355 - 361 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102205024A (en) | Ointment for treating burns and preparation method thereof | |
CN101869626B (en) | Chinese medicinal compound preparation private care liquid, and preparation and application thereof | |
CN101972338A (en) | Chinese medicinal preparation for treating infantile upper respiratory tract infection and preparation method thereof | |
CN104547775A (en) | Traditional Chinese medicine for treating syndrome of dampness-heat in middle jiao | |
CN102600417A (en) | Chinese medicinal composition for treating rumen bloat in cattle and sheep | |
CN106138733A (en) | One treats dermopathic Chinese medicinal ointment preparation and preparation method thereof | |
CN105902660A (en) | Pharmaceutical composition for treating bedsores, diabetic feet and eczema | |
CN101239162B (en) | Traditional Chinese medicine composition for treating stomach disease | |
CN114028486A (en) | Propolis stomach invigorating pill | |
CN105998551A (en) | Traditional Chinese medicine composition for treating stomachache and preparation method thereof | |
CN114377071A (en) | Traditional Chinese medicine enema and preparation method thereof | |
CN113181318A (en) | Traditional Chinese medicine ointment for treating haemorrhoids and preparation method thereof | |
CN105031595A (en) | Traditional Chinese medicine tablet for treating nummular eczema and preparing method thereof | |
CN104958757A (en) | Pressure sore paste and preparation method thereof | |
CN105031596A (en) | Ointment for treating nummular eczema and preparing method thereof | |
CN104324114A (en) | Traditional Chinese medicine preparation for treating dysentery | |
CN108273009A (en) | A kind of medicine pill for treating condyloma acuminatum | |
CN106822354A (en) | A kind of medicine for treating hemorrhoid | |
CN104873857A (en) | Traditional Chinese medicine for treating alimentary infection | |
CN110881658A (en) | Bowel-relaxing medicated diet and preparation method thereof | |
CN114028517A (en) | Fukangtong pill for women | |
CN105770538A (en) | Traditional Chinese medicine for treating local vascular access induration of hemodialysis patients | |
CN106421502A (en) | Pharmaceutical composition for treating infant jaundice | |
CN104435878A (en) | Traditional Chinese medicine preparation for treating infectious eczematous dermatitis | |
CN104887841A (en) | Traditional Chinese medicine preparation for treating gout |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
DD01 | Delivery of document by public notice |
Addressee: Chen Fengyu Document name: Notification of qualified procedures |
|
DD01 | Delivery of document by public notice | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |